Literature DB >> 27794107

Secular changes in cardiovascular risk factors in Swedish 50-year-old men over a 50-year period: The study of men born in 1913, 1923, 1933, 1943, 1953 and 1963.

You Zhong1,2, Annika Rosengren1, Michael Fu1, Lennart Welin1,3, Catharina Welin1, Kenneth Caidahl1,4, Zacharias Mandalenakis1, Mikael Dellborg1, Kurt Svärdsudd5, Per-Olof Hansson1.   

Abstract

Background During the past decades, declining trends in mean cholesterol levels and smoking have been observed in Western Europe, whereas obesity and a sedentary lifestyle have increased. Simultaneously, there has been a marked decrease in mortality from cardiovascular (CV) diseases. Methods The aim of the study was to determine whether these trends in CV risk factors continued over a period of 50 years. Six systematic or random population samples of 50-year-old men ( n = 3563) living in Gothenburg, Sweden, were investigated between 1963 and 2013. Results During the 50 years, mean body mass index (BMI) at 50 years of age increased by 2 kg/m2, from 24.8 kg/m2 in 1963 to 26.8 kg/m2 in 2013 ( p < 0.001). A decrease in systolic blood pressure of nearly 10 mmHg was observed from 1963 to 1993, but was not sustained through the past two decades. Mean serum cholesterol fell from 6.42 (SD 1.12) mmol/L to 5.34 (SD 0.97) mmol/L. The prevalence of smoking at 50 years of age decreased markedly from 56.1% in 1963 to 11.9% in 2013. The number of participants with a sedentary lifestyle during leisure time decreased until 1993, but has remained unchanged since. In 2013, 50-year-old men had a 6.9-times higher likelihood of lacking CV risk factors than 50-year-old men in 1963 (95% confidence interval (CI): 3.5-13.3, p < 0.001). The odds ratio for having four or more risk factors was only 0.13 (95% CI: 0.062-0.29, p < 0.001). Conclusion Despite increasing body weight, the total CV risk factor burden has decreased in 50-year-old men over the past 50 years.

Entities:  

Keywords:  Secular trends; cardiovascular risk factors; lifestyle; obesity

Mesh:

Substances:

Year:  2016        PMID: 27794107     DOI: 10.1177/2047487316676905

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  5 in total

1.  Why is COVID-19 especially impacting the African American population?

Authors:  Fabian Sanchis-Gomar; Giuseppe Lippi; Carl J Lavie
Journal:  Ann Med       Date:  2020-08-18       Impact factor: 4.709

2.  Secular trends in cardiovascular risk factors among women aged 45-54 years in Gothenburg, Sweden, from 1980 to 2014.

Authors:  Carina U Persson; Anna-Clara Collén; Annika Rosengren; Zacharias Mandalenakis; Tatiana Zverkova Sandström; Michael Fu; Mikael Dellborg; Saga Johansson; Per-Olof Hansson
Journal:  BMC Public Health       Date:  2020-07-01       Impact factor: 3.295

3.  Although Coronary Mortality Has Decreased, Rates of Cardiovascular Disease Remain High: 21 Years of Follow-Up Comparing Cohorts of Men Born in 1913 With Men Born in 1943.

Authors:  Michael Fu; Annika Rosengren; Erik Thunström; Zacharias Mandalenakis; Lennart Welin; Kenneth Caidahl; Aldina Pivodic; You Zhong; Constantinos Ergatoudes; David Morales; Catharina Welin; Kurt Svärdsudd; Mikael Dellborg; Per-Olof Hansson
Journal:  J Am Heart Assoc       Date:  2018-04-19       Impact factor: 5.501

4.  30-year trends in major cardiovascular risk factors in the Czech population, Czech MONICA and Czech post-MONICA, 1985 - 2016/17.

Authors:  Renata Cífková; Jan Bruthans; Peter Wohlfahrt; Alena Krajčoviechová; Pavel Šulc; Marie Jozífová; Lenka Eremiášová; Jan Pudil; Aleš Linhart; Jiří Widimský; Jan Filipovský; Otto Mayer; Zdenka Škodová; Rudolf Poledne; Petr Stávek; Věra Lánská
Journal:  PLoS One       Date:  2020-05-11       Impact factor: 3.240

5.  Effect of Secular Trend, Age, and Length of Follow-up on Optimum Body Mass Index From 1985 Through 2015 in a Large Austrian Cohort.

Authors:  Raphael Simon Peter; Bernhard Föger; Hans Concin; Gabriele Nagel
Journal:  J Epidemiol       Date:  2021-02-18       Impact factor: 3.211

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.